Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), lung cancer, and lymphoma (non-hodgkin's).

Investigated for use/treatment in lymphoma (unspecified), melanoma, and solid tumors.

Investigated for use/treatment in leukemia (lymphoid).

Investigated for use/treatment in hyperlipidemia and cancer/tumors (unspecified). Monotherapy is recommended for people with marginally high LDL-cholesterol or who cannot be ...

Investigated for use/treatment in cardiovascular disorders, in the treatment of syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) and in hyponatremia.

Investigated for use/treatment in colorectal cancer, hepatitis (viral, B), and lymphoma (non-hodgkin's). ISS 1018 is currently being investigated in combination with HBsAg vaccine...

Investigated for use/treatment in autoimmune diseases, cancer/tumors (unspecified), lymphoma (non-hodgkin's), and lymphoma (unspecified).

Investigated for use/treatment in cancer/tumors (unspecified), leukemia (unspecified), lymphoma (unspecified), multiple myeloma, and pancreatic cancer.

Treating chronic hepatitis C virus (genotype 1) infection in patients with compensated liver (due to liver diseases like cirrhosis) that are treatment naive or have failed therapy ...

Used in patients with homozygous familial hypercholesterolemia as an adjunct to diet and other lipid-lowering medications.

Investigated for use/treatment in cancer/tumors (unspecified), leukemia (lymphoid), leukemia (myeloid), lymphoma (non-hodgkin's), lymphoma (unspecified), myelodysplastic syndrome, ...

Investigated for use/treatment in lymphoma (unspecified), macular degeneration, prostate cancer, and solid tumors.

Investigated for use/treatment in addictions and alcohol dependence.

Investigated for use/treatment in leukemia (lymphoid).

Investigated for use/treatment in onychomycosis.

Investigated for use/treatment in hepatitis (viral, C), leukemia (myeloid), and lymphoma (non-hodgkin's).

Investigated for use/treatment in lung cancer and lymphoma (unspecified).

Used in HER2-positive, metastatic breast cancer patients who have already used taxane and/or trastuzumab for metastatic disease or had their cancer recur within 6 months of ...

Investigated for use/treatment in lymphoma (non-hodgkin's).

Investigated for use/treatment in blood (blood forming organ disorders, unspecified), lymphoma (unspecified), and multiple myeloma.